# Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

> **NCT04634513** · PHASE1 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 53 (actual)

## Conditions studied

- Shigella Infection
- Enterotoxigenic Escherichia Coli Infection

## Interventions

- **BIOLOGICAL:** strain CVD 1208S-122
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04634513
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-29
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04634513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04634513, "Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04634513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*